CompanyNovartis Europharm Limited
ATC codeS01XA27
EU authorised2018-11-22
· 7 yr ago
Flags
Orphan
EMA EPAR
Evidence dossier ↗
Luxturna CONFIRMED
voretigene neparvovec · RPE65 retinal dystrophy
Current stage: 6 · first detected 2026-06-25
Also known as: luxturna
Nordic decisions
| Country | Body | Verdict | Date | Source |
|---|---|---|---|---|
| Danmark | Medicinrådet | Anbefalet | 2025-06-18 | link |
| Sverige | NT-rådet | bör användas | 2022-12-12 | link |
Status timeline
| Date | Body | Status | Stage | Source |
|---|---|---|---|---|
| No status history. | ||||